Shingo Arakawa
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Glutathione Transferases and Polymorphisms 7
- Genomics, phytochemicals, and oxidative stress 3
- Peroxisome Proliferator-Activated Receptors 3
- Metabolism, Diabetes, and Cancer 2
-
- Pharmacogenetics and Drug Metabolism 6
- Drug-Induced Hepatotoxicity and Protection 3
- Co-authors
- Ryo Atsumi (2 shared papers)Hiromi Okamoto (1 shared paper)Katsunobu Hagihara (1 shared paper)Ichiro Hayakawa (1 shared paper)Masataka Oitate (1 shared paper)Junko Yamaguchi (1 shared paper)Takehiro Hirai (1 shared paper)Yusuke Ogitani (1 shared paper)
In The Last Decade
Shingo Arakawa
23 papers receiving 1.2k citations
Shingo Arakawa's Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 722
- Pharmacology 164
- Radiology, Nuclear Medicine and Imaging 348
- Pulmonary and Respiratory Medicine 210
- Aging 11
Countries citing papers authored by Shingo Arakawa
This map shows the geographic impact of Shingo Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Arakawa more than expected).
Fields of papers citing papers by Shingo Arakawa
This network shows the impact of papers produced by Shingo Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Arakawa. The network helps show where Shingo Arakawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Shingo Arakawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1 Hit paper breakdown → | 2016 | 807 |
| 2 | 2003 | 92 | |
| 3 | 2009 | 77 | |
| 4 | 2005 | 27 | |
| 5 | 2011 | 27 | |
| 6 | 2016 | 24 | |
| 7 | 2013 | 22 | |
| 8 | 2006 | 21 | |
| 9 | 2020 | 17 | |
| 10 | 2007 | 17 | |
| 11 | 2012 | 16 | |
| 12 | 2013 | 14 | |
| 13 | 2009 | 14 | |
| 14 | 2010 | 13 | |
| 15 | 2013 | 13 | |
| 16 | 2011 | 12 | |
| 17 | 2020 | 11 | |
| 18 | 2008 | 6 | |
| 19 | 2005 | 5 | |
| 20 | 2010 | 5 |
About Shingo Arakawa
Shingo Arakawa is a scholar working on Molecular Biology, Pharmacology, Oncology, Physiology and Pathology and Forensic Medicine, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Glutathione Transferases and Polymorphisms (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Metabolism, Diabetes, and Cancer (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (722 citations), Pharmacology (164 citations), Radiology, Nuclear Medicine and Imaging (348 citations), Pulmonary and Respiratory Medicine (210 citations) and Aging (11 citations). Shingo Arakawa has collaborated with scholars based in Japan, Germany and India. Frequent co-authors include Ryo Atsumi, Hiromi Okamoto, Katsunobu Hagihara, Ichiro Hayakawa, Masataka Oitate, Junko Yamaguchi, Takehiro Hirai, Yusuke Ogitani, Yuki Abe and Tetsuo Aida. Their work appears in journals such as Drug Metabolism and Disposition, Scientific Reports, Molecular Pharmacology, Toxicologic Pathology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.